Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maria Letizia Barreca

Showing results (1-10 of 102) with videos related to

Pageof 11
Sort By:
Future Medicinal Chemistry|December 23, 2015
Maria Letizia Barreca on hepatitis C virus treatment and controlMaria Letizia Barreca
Sub-Cellular Biochemistry|September 26, 2025
Therapeutic Trajectories in Human Prion DiseasesMaria Letizia Barreca, Emiliano Biasini
Future Medicinal Chemistry|June 29, 2011
Allosteric inhibition of the hepatitis C virus NS5B polymerase: in silico strategies for drug discovery and developmentMaria Letizia Barreca, Nunzio Iraci, Giuseppe Manfroni, et al.
Virus Research|December 3, 2014
Decoding the function of the N-terminal tail of the cellular prion protein to inspire novel therapeutic avenues for neurodegenerative diseasesNunzio Iraci, Claudia Stincardini, Maria Letizia Barreca, et al.
ACS Medicinal Chemistry Letters|November 19, 2020
The Compelling Demand for an Effective PrP<sup>C</sup>-Directed Therapy against Prion DiseasesAndrea Astolfi, Giovanni Spagnolli, Emiliano Biasini, et al.
Pharmaceuticals (Basel, Switzerland)|July 29, 2023
Computer-Aided Identification of Kinase-Targeted Small Molecules for Cancer: A Review on AKT ProteinErika Primavera, Deborah Palazzotti, Maria Letizia Barreca, et al.
Journal of Medicinal Chemistry|August 5, 2015
A Journey around the Medicinal Chemistry of Hepatitis C Virus Inhibitors Targeting NS4B: From Target to Preclinical Drug CandidatesRolando Cannalire, Maria Letizia Barreca, Giuseppe Manfroni, et al.
Chemmedchem|December 7, 2017
A Comprehensive Structural Overview of p38α Mitogen-Activated Protein Kinase in Complex with ATP-Site and Non-ATP-Site BindersAndrea Astolfi, Giuseppe Manfroni, Violetta Cecchetti, et al.
Journal of Medicinal Chemistry|June 23, 2006
Binding mode prediction of strand transfer HIV-1 integrase inhibitors using Tn5 transposase as a plausible surrogate model for HIV-1 integraseMaria Letizia Barreca, Laura De Luca, Nunzio Iraci, et al.
Chemmedchem|June 23, 2009
Induced-fit docking approach provides insight into the binding mode and mechanism of action of HIV-1 integrase inhibitorsMaria Letizia Barreca, Nunzio Iraci, Laura De Luca, et al.
Pageof 11

Showing results (1-10 of 102) with videos related to

Sort By:
Pageof 11
Future Medicinal Chemistry|December 23, 2015
Maria Letizia Barreca on hepatitis C virus treatment and controlMaria Letizia Barreca
Sub-Cellular Biochemistry|September 26, 2025
Therapeutic Trajectories in Human Prion DiseasesMaria Letizia Barreca, Emiliano Biasini
Future Medicinal Chemistry|June 29, 2011
Allosteric inhibition of the hepatitis C virus NS5B polymerase: in silico strategies for drug discovery and developmentMaria Letizia Barreca, Nunzio Iraci, Giuseppe Manfroni, et al.
Virus Research|December 3, 2014
Decoding the function of the N-terminal tail of the cellular prion protein to inspire novel therapeutic avenues for neurodegenerative diseasesNunzio Iraci, Claudia Stincardini, Maria Letizia Barreca, et al.
ACS Medicinal Chemistry Letters|November 19, 2020
The Compelling Demand for an Effective PrP<sup>C</sup>-Directed Therapy against Prion DiseasesAndrea Astolfi, Giovanni Spagnolli, Emiliano Biasini, et al.
Pharmaceuticals (Basel, Switzerland)|July 29, 2023
Computer-Aided Identification of Kinase-Targeted Small Molecules for Cancer: A Review on AKT ProteinErika Primavera, Deborah Palazzotti, Maria Letizia Barreca, et al.
Journal of Medicinal Chemistry|August 5, 2015
A Journey around the Medicinal Chemistry of Hepatitis C Virus Inhibitors Targeting NS4B: From Target to Preclinical Drug CandidatesRolando Cannalire, Maria Letizia Barreca, Giuseppe Manfroni, et al.
Chemmedchem|December 7, 2017
A Comprehensive Structural Overview of p38α Mitogen-Activated Protein Kinase in Complex with ATP-Site and Non-ATP-Site BindersAndrea Astolfi, Giuseppe Manfroni, Violetta Cecchetti, et al.
Journal of Medicinal Chemistry|June 23, 2006
Binding mode prediction of strand transfer HIV-1 integrase inhibitors using Tn5 transposase as a plausible surrogate model for HIV-1 integraseMaria Letizia Barreca, Laura De Luca, Nunzio Iraci, et al.
Chemmedchem|June 23, 2009
Induced-fit docking approach provides insight into the binding mode and mechanism of action of HIV-1 integrase inhibitorsMaria Letizia Barreca, Nunzio Iraci, Laura De Luca, et al.
Pageof 11